94 results
8-K
EX-4.1
LEXX
Lexaria Bioscience Corp
30 Apr 24
Entry into a Material Definitive Agreement
3:13pm
voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i), except
424B3
LEXX
Lexaria Bioscience Corp
20 Mar 24
Prospectus supplement
5:00pm
common stock have no cumulative voting rights. Further, holders of our common stock have no preemptive or conversion rights or other subscription
8-K
EX-4.3
LEXX
Lexaria Bioscience Corp
16 Feb 24
Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:30pm
not entitle the Holder to any voting rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth
8-K
EX-4.2
vkov46w5g
16 Feb 24
Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:30pm
8-K
EX-4.1
5dpntovlg
16 Feb 24
Lexaria Announces $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:30pm
424B5
mgznn2mxc
16 Feb 24
Prospectus supplement for primary offering
6:01am
POS AM
0e24kndyldj
24 Jan 24
Prospectus update (post-effective amendment)
1:33pm
S-8
EX-4.1
rhq51nz5j5zikp622
18 Jan 24
Registration of securities for employees
2:38pm
424B3
91k8whbc 77zcq
8 Dec 23
Prospectus supplement
4:31pm
8-K
EX-4.1
wajhoxsski9ss9dlqdn
3 Oct 23
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-4.2
vzdedw14x
3 Oct 23
Entry into a Material Definitive Agreement
4:05pm
424B5
vhr5l 3c9
2 Oct 23
Prospectus supplement for primary offering
4:06pm
424B4
ur1uv3poa 9ov59
10 May 23
Prospectus supplement with pricing info
4:30pm